According Newswise, in a new study first published in Gastroenterology, researchers at Cedars-Sinai have identified a set of genes, made up of rare genetic deviations
In a recent press release, gene therapy company Orchard Therapeutics (“Orchard”) announced that the FDA approved Orchard’s Investigational New Drug (IND) application for OTL-200.
According to a report in BioPharma Dive, Brainstorm Therapeutics, a New York biotechnology company, said that while its NurOwn therapy for amyotrophic lateral sclerosis
Recently, the American College of Rheumatology (ACR) virtually held ACR Convergence 2020, the organization’s annual meeting. At the meeting, researchers shared new insights in the
A recent article in BioSpace highlighted presentations by Twist Bioscience, a rapidly growing genomic and synthetic biology company. Twist presented its product line at the
As reported in Medical Xpress; Fight for Sight, a charity in the UK dedicated to vision, has an exciting announcement for people with macular diseases:
© Copyright Patient Worthy
